Literature DB >> 4463958

Calcium-induced dissociation of human plasma factor XIII and the appearance of catalytic activity.

R D Cooke.   

Abstract

1. The Ca(2+) dependence of the activity of plasma Factor XIII(a) was studied by using the continuous assay based on the incorporation of dansylcadaverine into dephosphorylated acetylated beta-casein (beta-substrate). The K(m) for Ca(2+) is about 0.170mm. 2. At low concentrations of Ca(2+) there was a lag in attaining the steady-state rate. The size of the lag was decreased and eventually abolished if the enzyme was preincubated with a high concentration of Ca(2+) before assay. The concentration of Ca(2+) required to decrease the lag phase by 50% in 10min depended on the protein concentration: at 0.87mg of protein/ml it required 17mm-Ca(2+) and at 0.44mg/ml it needed 10mm-Ca(2+). 3. The concentrations of Ca(2+) required either to abolish the lag phase in the appearance of enzyme activity or to activate the essential thiol for reaction with 5,5'-dithiobis-(2-nitrobenzoate) in 10min incubation were similar at the same protein concentration. This indicated that Ca(2+) induces a conformation change that is responsible for both phenomena. A model is proposed that links this conformation change to the dissociation of the tetrameric enzyme. 4. This was supported by the observation that the addition of excess of b chains to the Factor XIII(a) (a'(2)b(2)) increased the concentration of Ca(2+) required to expose the reactive thiol, and inhibited the Ca(2+)-dependent aggregation of a' chains. 5. Platelet Factor XIII(a) (a'(2)) was inhibited by 5,5'-dithiobis-(2-nitrobenzoate) in the absence of Ca(2+), and no lag phases were observed in attaining the steady-state rate at low Ca(2+) concentrations, thus confirming the model for the activation of the plasma enzyme. 6. The Ca(2+) dependence of platelet Factor XIII(a) indicated that Ca(2+) has an additional role in the enzyme mechanism of the plasma enzyme, perhaps being involved in substrate binding. 7. The dependence of the stability of plasma Factor XIII(a) on Ca(2+) and protein concentration indicates that the decay in activity is related to the tetramer dissociation. 8. beta-Substrate decreased the Ca(2+) concentration required for (1) abolition of the lag phase and (2) enzyme inhibition by thiol reagents. The effect on the former is greater than on the latter. 9. The role of the b chains of the plasma Factor and the evolutionary significance of the plasma and platelet Factors are considered.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4463958      PMCID: PMC1168173          DOI: 10.1042/bj1410683

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  33 in total

1.  CHARACTERIZATION OF SOME PROTEINS FROM NORMAL HUMAN PLATELETS.

Authors:  A BEZKOROVAINY; M E RAFELSON
Journal:  J Lab Clin Med       Date:  1964-08

2.  Plasma fibrin-stabilizing factor: acquired deficiency in various disorders.

Authors:  E E Mandel; W M Gerhold
Journal:  Am J Clin Pathol       Date:  1969-11       Impact factor: 2.493

3.  Factor XIII assay by an isotope method. I. Factor XIII (transamidase) in plasma, serum, leucocytes, erythrocytes and platelets and evaluation of screening tests of clot solubility.

Authors:  A Dvilansky; A F Britten; A G Loewy
Journal:  Br J Haematol       Date:  1970-04       Impact factor: 6.998

4.  Bovine platelet proteins. 3. Some properties of platelet fibrinogen.

Authors:  N O Solum; S Lopaciuk
Journal:  Thromb Diath Haemorrh       Date:  1969-06-15

5.  Mechanism of action of guinea pig liver transglutaminase. VI. Order of substrate addition.

Authors:  J E Folk
Journal:  J Biol Chem       Date:  1969-07-10       Impact factor: 5.157

6.  Mechanism of action of guinea pig liver transglutaminase. II. The role of metal in enzyme activation.

Authors:  J E Folk; J P Mullooly; P W Cole
Journal:  J Biol Chem       Date:  1967-04-25       Impact factor: 5.157

7.  Immunologic studies of proteins associated with subcellular fractions of normal human platelets.

Authors:  R L Nachman; A J Marcus; D Zucker-Franklin
Journal:  J Lab Clin Med       Date:  1967-04

8.  Factor XIII in human plasma and platelets.

Authors:  J McDonagh; R P McDonagh; J M Delâge; R H Wagner
Journal:  J Clin Invest       Date:  1969-05       Impact factor: 14.808

9.  [Cross-link in fibrin polymerized by factor 13: epsilon-(gamma-glutamyl)lysine].

Authors:  J J Pisano; J S Finlayson; M P Peyton
Journal:  Science       Date:  1968-05-24       Impact factor: 47.728

10.  Platelet fibrinogen.

Authors:  P A Castaldi; J Caen
Journal:  J Clin Pathol       Date:  1965-09       Impact factor: 3.411

View more
  7 in total

1.  Coagulation factor XIII B subunit is encoded by a gene linked to the regulator of complement activation (RCA) gene cluster in man.

Authors:  S Rodriguez de Cordoba; J Rey-Campos; D D Dykes; P J McAlpine; P Wong; P Rubinstein
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

2.  Factor XIII topology: organization of B subunits and changes with activation studied with single-molecule atomic force microscopy.

Authors:  Anna D Protopopova; Andrea Ramirez; Dmitry V Klinov; Rustem I Litvinov; John W Weisel
Journal:  J Thromb Haemost       Date:  2019-03-14       Impact factor: 5.824

Review 3.  Viscoelasticity and Ultrastructure in Coagulation and Inflammation: Two Diverse Techniques, One Conclusion.

Authors:  Albe C Swanepoel; Vance G Nielsen; Etheresia Pretorius
Journal:  Inflammation       Date:  2015-08       Impact factor: 4.092

4.  Protein-protein interactions in blood clotting. The use of polarization of fluorescence to measure the dissociation of plasma factor XIIIa.

Authors:  J M Freyssinet; B A Lewis; J J Holbrook; J D Shore
Journal:  Biochem J       Date:  1978-02-01       Impact factor: 3.857

5.  An equilibrium study of metal ion binding to human plasma coagulation factor XIII.

Authors:  B A Lewis; J M Freyssinet; J J Holbrook
Journal:  Biochem J       Date:  1978-02-01       Impact factor: 3.857

6.  Calcium and thiol reactivity of human plasma clotting factor XIII.

Authors:  R D Cooke; T C Pestell; J J Holbrook
Journal:  Biochem J       Date:  1974-09       Impact factor: 3.857

7.  Non-proteolytic activation of cellular protransglutaminase (placenta macrophage factor XIII).

Authors:  J Polgár; V Hidasi; L Muszbek
Journal:  Biochem J       Date:  1990-04-15       Impact factor: 3.857

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.